What you’ll learn and discuss:

• How quantum-based materials and advanced platforms enable ultrasensitive disease detection.

• The integration of real-time biosensing technologies with clinical data pipelines.

• The vital role of clinicians in defining needs, validating prototypes, and driving early adoption.

• Practical strategies for translating technologies from the lab to the clinic in a patient-centered, scalable way.

The session blends company presentations, clinician insights, and a moderated panel discussion to uncover actionable pathways for closer collaboration between innovators and frontline healthcare providers. Attendees will leave with ideas and connections to help turn diagnostic concepts into real-world solutions.

Facilitators/Speakers:

• Moderator: Jennifer Reid- The Alberta Diagnostics Ecosystem Platform for Translation (ADEPT)

• Applied Quantum Materials (AQM): Dr. Dorra Gargouri- Innovations in nanomaterials for biosensing and diagnostics

• BioStream Diagnostics: John Murphy- Lab quality testing from home

• Pavonis: Dr. Todd McMullen– Innovative Diagnostic platforms and clinician engagement

• Clinician Insights – Defining real-world needs and adoption barriers

Who should attend:

• Clinicians and physician-scientists

• Academic researchers and scientists

• Healthcare technology startups and innovators

• Biotech and med-tech companies

• Hospital innovation hubs and clinical trials units

• Investors and venture builders in health-tech

• Policy makers and health system leaders